Concord Biotech Share Price
1419.30-28.40 (-1.96%)
-16.46% past 1 Year
Concord Biotech Limited is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology, supplying too many countries including
Corporate filings & documents
Announcements
We would like to inform you that the officials of the Company will be attending an Investor Conference on 26th August 2026 as per the schedule and details in the file uploaded herewith.
2 weeks agoWe would like to inform you that the officials of the Company will be attending an Investor Conference on 26th August 2026 as per the schedule and details in the file uploaded herewith.
2 weeks agoTranscript of Q1 - FY27 Earnings call held on August 03 2026
3 weeks agoTranscript of Q1 - FY27 Earnings call held on August 03 2026
3 weeks agoThe audio recording of the conference held on August 03 2026 has been hosted on the website of the company and link to access the said recording is as follows: - Link : https://concordbiotech.com/wp-content/uploads/2026/08/Concord-Biotech-Q1-FY27-Earnings-Call-Audio-Recording.mp3
1 month agoThe audio recording of the conference held on August 03 2026 has been hosted on the website of the company and link to access the said recording is as follows: - Link : https://concordbiotech.com/wp-content/uploads/2026/08/Concord-Biotech-Q1-FY27-Earnings-Call-Audio-Recording.mp3
1 month agoInvestors Presentation on unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30 2026
1 month agoInvestors Presentation on unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30 2026
1 month agoPursuant to regulation 44(3) of the SEBI (LODR) Regulations 2015 and section 108 of the Companies Act 2013 the voting results along with the scrutinizers report for the business items transacted at the 41st Annual General Meeting of the Company held on July 31 2026 are published herewith.
1 month agoPursuant to regulation 44(3) of the SEBI (LODR) Regulations 2015 and section 108 of the Companies Act 2013 the voting results along with the scrutinizers report for the business items transacted at the 41st Annual General Meeting of the Company held on July 31 2026 are published herewith.
1 month agoNewspaper publication cutouts of unaudited Standalone and Consolidated Financial results for the first quarter ended June 30 2026
1 month agoNewspaper publication cutouts of unaudited Standalone and Consolidated Financial results for the first quarter ended June 30 2026
1 month agoThe 41st Annual General Meeting Meeting of the Members of the Company was held on Friday July 31 2026 at 12:00 Noon through VC/OAVM. The summary of the proceedings are published herewith.
1 month agoThe 41st Annual General Meeting Meeting of the Members of the Company was held on Friday July 31 2026 at 12:00 Noon through VC/OAVM. The summary of the proceedings are published herewith.
1 month agoUnaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026
1 month agoUnaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026
1 month agoWe would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Friday July 31 2026 on review and recommendation of Audit Committee of the Company has inter-alia considered and approved the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026.
1 month agoWe would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Friday July 31 2026 on review and recommendation of Audit Committee of the Company has inter-alia considered and approved the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026.
1 month agoPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended on June 30 2026 scheduled on Monday August 03 2026 at 3:30 P.M. IST. The Earnings Call invite is enclosed for your records.
1 month agoPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 as amended from time to time read with Para A of Schedule III thereto We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended on June 30 2026 scheduled on Monday August 03 2026 at 3:30 P.M. IST. The Earnings Call invite is enclosed for your records.
1 month agoConcord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026 along with Limited Review Report thereon to be issued by the Statutory Auditors.
1 month agoConcord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30 2026 along with Limited Review Report thereon to be issued by the Statutory Auditors.
1 month agoNewspaper Advertisement for Notice of 41st Annual General Meeting Book Closure and Remove e-voting information
1 month agoNewspaper Advertisement for Notice of 41st Annual General Meeting Book Closure and Remove e-voting information
1 month agoThe register of members and share transfer book of the Company will be closed from Saturday July 25 2026 to Friday July 31 2026. Further the Company has fixed Friday July 24 2026 as the "Record Date" for the purpose of determining the entitlement of Members to receive final dividend for the financial year ended March 31 2026 and 41st Annual General Meeting.
1 month agoThe register of members and share transfer book of the Company will be closed from Saturday July 25 2026 to Friday July 31 2026. Further the Company has fixed Friday July 24 2026 as the "Record Date" for the purpose of determining the entitlement of Members to receive final dividend for the financial year ended March 31 2026 and 41st Annual General Meeting.
1 month agoBusiness Responsibility and Sustainability Report for financial year 2025-26
1 month agoBusiness Responsibility and Sustainability Report for financial year 2025-26
1 month agoAnnual Report for the financial year 2025-26
1 month agoAnnual Report for the financial year 2025-26
1 month agoThe Notice of 41st Annual General Meeting of the Company of scheduled to be held on Friday July 31 2026 through Video Conferencing (VC) / Other Audio-visual means(OAVM) at 12:00 Noon is enclosed herewith.
1 month agoThe Notice of 41st Annual General Meeting of the Company of scheduled to be held on Friday July 31 2026 through Video Conferencing (VC) / Other Audio-visual means(OAVM) at 12:00 Noon is enclosed herewith.
1 month agoNewspaper advertisement for Notice of 41st Annual General Meeting.
1 month agoNewspaper advertisement for Notice of 41st Annual General Meeting.
1 month agoIn compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we furnish herewith certificate dated July 01 2026 issued by MUFG Intime India Private Limited for the quarter ended June 30 2026.
2 months agoIn compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we furnish herewith certificate dated July 01 2026 issued by MUFG Intime India Private Limited for the quarter ended June 30 2026.
2 months agoPursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and as per the Companys code of conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for trading in Equity Shares of the Company will be closed from July 01 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30 2026.
2 months agoPursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and as per the Companys code of conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for trading in Equity Shares of the Company will be closed from July 01 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30 2026.
2 months agoWe are pleased to announce the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit - II formulation facility.
2 months agoWe are pleased to announce the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit - II formulation facility.
2 months agoWe are pleased to announce that the Company has entered into an agreement to Invest in M/s. FSGE Renewable Power Private Limited for installation of Wind Solar Hybrid Power Project having a wind capacity of approximately 6.3 MW AC & solar capacity of approximately 6.3 MWp DC in Gujarat for Limbasi Facility of the Company.
2 months agoWe are pleased to announce that the Company has entered into an agreement to Invest in M/s. FSGE Renewable Power Private Limited for installation of Wind Solar Hybrid Power Project having a wind capacity of approximately 6.3 MW AC & solar capacity of approximately 6.3 MWp DC in Gujarat for Limbasi Facility of the Company.
2 months agoIntimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled to be held on 24th & 25th June 2026.
2 months agoIntimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled to be held on 24th & 25th June 2026.
2 months agoIntimation of Schedule of Analyst / Institutional Investor meeting to be held on June 17 2026 at 10:30 AM
2 months agoIntimation of Schedule of Analyst / Institutional Investor meeting to be held on June 17 2026 at 10:30 AM
2 months agoWe are pleased to announce the successful completion of an ANVISA inspection conducted by the Brazilian Health Regulatory Agency at our API manufacturing facility in Limbasi. The inspection took place from June 8 to June 12 2026 and was concluded successfully.
2 months agoWe are pleased to announce the successful completion of an ANVISA inspection conducted by the Brazilian Health Regulatory Agency at our API manufacturing facility in Limbasi. The inspection took place from June 8 to June 12 2026 and was concluded successfully.
2 months agoWe are pleased to inform that the Company has received approval from USFDA for its ANDA for Tofacitinib Tablets 5 mg and 10 mg.
2 months agoWe are pleased to inform that the Company has received approval from USFDA for its ANDA for Tofacitinib Tablets 5 mg and 10 mg.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Jul 2026
ConcallPresentation
Jun 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Sept 2023
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-24
Dividend
7.55
2025-09-03
Dividend
10.7
2024-06-21
Dividend
8.75
Company details
Registered office
1482-1486 Trasad Road Dholka Ahmedabad Dist Gujarat PIN: 382225 Tel No: 02714-222604 / 398200 Fax No: 02714-222504 Email: [email protected] Internet: www.concordbiotech.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Paritosh Trivedi, Company Secretary & Compliance Officer
Sudhir Vaid, Chairman & Managing Director
Sudhir Vaid, Chairman & Managing Director
Ankur Vaid, Joint Managing Director & Chief Executive Officer
Amitabh Thakore, Non Executive Independent Director
Arvind Agarwal, Non Executive Independent Director
Bharti Khanna, Non Executive Independent Director
Jayaram Easwaran, Non Executive Independent Director
Ravi Kapoor, Non Executive Director
Rajiv Agarwal, Non Executive Director
Mandayam Chakravarthy Sriraman, Non Executive Independent Director
Details
BSE 543960
NSE CONCORDBIO
ISIN INE338H01029